Silofast Capsule 8 mg contains Silodosin, an alpha-1 adrenergic receptor antagonist primarily used in the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that causes urinary difficulties in men. Silodosin works by selectively relaxing the smooth muscles of the prostate gland and bladder neck, improving urine flow and reducing symptoms associated with BPH, such as urinary frequency, urgency, weak stream, and nocturia.
This selective alpha-1 blocker targets alpha-1A receptors predominantly found in the prostate and lower urinary tract, which allows for effective relief of urinary symptoms while minimizing effects on blood pressure. Silofast Capsule 8 mg is recommended for men experiencing lower urinary tract symptoms (LUTS) due to BPH and helps improve quality of life by alleviating discomfort associated with urinary obstruction.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Silodosin 8 mg per capsule
Silofast works by selectively blocking alpha-1A adrenergic receptors:
Relaxes smooth muscles in the prostate, bladder neck, and urethra
Reduces resistance to urinary flow
Improves urine passage, reducing hesitancy and incomplete emptying
Minimizes systemic blood pressure effects due to selective alpha-1A targeting
By targeting the alpha-1A receptors specifically, Silodosin provides symptomatic relief without causing significant orthostatic hypotension or dizziness often associated with non-selective alpha blockers.
Silofast Capsule 8 mg is indicated for:
Treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)
Improvement of urinary flow rate and reduction of obstructive urinary symptoms
Relief of urinary hesitancy, straining, incomplete bladder emptying, and nocturia
Long-term management of BPH-related urinary difficulties
The recommended dose is 8 mg once daily, preferably taken after a meal to improve absorption.
Swallow the capsule whole with water; do not crush or chew.
Consistent daily intake at the same time each day ensures optimal therapeutic effect.
Dose adjustments may be necessary in patients with moderate renal or hepatic impairment, under physician supervision.
Selective alpha-1A blockade reduces BPH symptoms effectively
Improves urinary flow and reduces straining during urination
Minimizes lower urinary tract symptoms, including urgency, frequency, and nocturia
Low risk of systemic hypotension due to receptor selectivity
Enhances overall quality of life for patients with BPH
Use cautiously in patients with severe renal or hepatic impairment
Patients with a history of orthostatic hypotension, cardiovascular disorders, or concurrent antihypertensive therapy should be monitored
Avoid sudden discontinuation without consulting a physician
Consult a healthcare provider before use in elderly patients or those with multiple comorbidities
Common side effects include:
Dizziness or lightheadedness, particularly when standing
Headache
Retrograde ejaculation (reversible upon discontinuation)
Nasal congestion
Diarrhea or mild gastrointestinal upset
Rare but serious side effects:
Severe hypotension
Allergic reactions including rash or swelling
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.
Silofast Capsule 8 mg offers effective relief from urinary symptoms caused by BPH through selective alpha-1A receptor blockade, improving urine flow and enhancing daily comfort and quality of life for men with benign prostatic hyperplasia.
Login Or Registerto submit your questions to seller
No none asked to seller yet